The major objectives of this project are to study the distribution, structure, metabolism, and function of glycosphingolipids (GSLs), particularly gangliosides, in normal and pathological tissues, cells and subcellular organelles of the CNS. We will engage in the isolation and characterization of new GSLs and in the elucidation of new biosynthetic pathways. We will develop new methodologies for investigating their subcellular localization and turnover, and for their chemical synthesis. We will also develop new strategies for elucidating their primary and secondary structures and relate this information to their functional role in biological membranes. The relationship between myelin and oligodendroglia will be examined through the metabolism of components that are intrinsic to these two compartments during brain development. Special emphasis will be placed on the functional role of myelin lipid-protein interactions in myelination and the maintenance of myelin membrane integrity. The mode of myelin lipid-protein interaction will be investigated by such physical techniques as nuclear magnetic resonance spectrometry and differential scanning calorimetry. This knowledge is essential in understanding the physiological role of myelin-associated neuraminidase and the regulation of proteolysis of myelin basic protein myelination and demyelination. Finally, we will investigate the pathogenesis of slow virus agents by studying the composition and metabolism of membrane ganglioside in scrapie mouse brains. We also plan to investigate the expression of gangliosides in a variety of neurological diseases and in an animal model which exhibit astrocytosis in order to better understand the relationship between abnormal ganglioside metabolism and physiological dysfunction in these neurological disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS011853-13
Application #
3394617
Study Section
Neurology B Subcommittee 1 (NEUB)
Project Start
1978-06-01
Project End
1988-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
13
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Itokazu, Yutaka; Wang, Jing; Yu, Robert K (2018) Gangliosides in Nerve Cell Specification. Prog Mol Biol Transl Sci 156:241-263
Itokazu, Yutaka; Tsai, Yi-Tzang; Yu, Robert K (2017) Epigenetic regulation of ganglioside expression in neural stem cells and neuronal cells. Glycoconj J 34:749-756
Tsai, Yi-Tzang; Itokazu, Yutaka; Yu, Robert K (2016) GM1 Ganglioside is Involved in Epigenetic Activation Loci of Neuronal Cells. Neurochem Res 41:107-15
Yu, Robert K; Usuki, Seigo; Itokazu, Yutaka et al. (2016) Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro. Glycobiology 26:63-73
Koon, Noah A; Itokazu, Yutaka; Yu, Robert K (2015) Ganglioside-Dependent Neural Stem Cell Proliferation in Alzheimer's Disease Model Mice. ASN Neuro 7:
Itokazu, Yutaka; Yu, Robert K (2014) Amyloid ?-peptide 1-42 modulates the proliferation of mouse neural stem cells: upregulation of fucosyltransferase IX and notch signaling. Mol Neurobiol 50:186-96
Usuki, Seigo; O'Brien, Dawn; Rivner, Michael H et al. (2014) A new approach to ELISA-based anti-glycolipid antibody evaluation of highly adhesive serum samples. J Immunol Methods 408:52-63
Parameswaran, Reshmi; Lim, Min; Arutyunyan, Anna et al. (2013) O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia. J Exp Med 210:805-19
Wang, Jing; Yu, Robert K (2013) Interaction of ganglioside GD3 with an EGF receptor sustains the self-renewal ability of mouse neural stem cells in vitro. Proc Natl Acad Sci U S A 110:19137-42
Ariga, Toshio; Itokazu, Yutaka; McDonald, Michael P et al. (2013) Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1a?. ASN Neuro 5:141-8

Showing the most recent 10 out of 199 publications